Electrophysiological features of chronic inflammatory demyelinating polyradiculoneuropathy associated with IgG4 antibodies targeting neurofascin 155 or contactin 1 glycoproteins

Détails

ID Serval
serval:BIB_2110DAD8CA2A
Type
Article: article d'un périodique ou d'un magazine.
Collection
Publications
Institution
Titre
Electrophysiological features of chronic inflammatory demyelinating polyradiculoneuropathy associated with IgG4 antibodies targeting neurofascin 155 or contactin 1 glycoproteins
Périodique
Clinical Neurophysiology
Auteur⸱e⸱s
Kouton Ludivine, Boucraut José, Devaux Jérome, Rajabally Yusuf A., Adams David, Antoine Jean Christophe, Bourdain Frédéric, Brodovitch Alexandre, Camdessanché Jean-Philippe, Cauquil Cécile, Ciron Jonathan, Dubard Thierry, Echaniz-Laguna Andoni, Grapperon Aude-Marie, Juntas-Morales Raul, Kremer Laurent, Kuntzer Thierry, Labeyrie Céline, Lanfranco Luca, Léger Jean-Marc, Maisonobe Thierry, Mavroudakis Nicolas, Mecharles-Darrigol Sylvie, Merle Philippe, Noury Jean-Baptiste, Rouaud Violaine, Tard Céline, Théaudin Marie, Vallat Jean-Michel, Viala Karine, Attarian Shahram, Delmont Emilien
ISSN
1388-2457
Statut éditorial
Publié
Date de publication
04/2020
Volume
131
Numéro
4
Pages
921-927
Langue
anglais
Résumé
OBJECTIVE: Chronic inflammatory demyelinating polyradiculoneuropathies (CIDP)
with antibodies against neurofascin 155 (Nfasc155) or contactin-1 (CNTN1) have
distinctive clinical features. Knowledge on their electrophysiological
characteristics is still scarce. In this study, we are investigating whether
these patients have specific electrophysiological characteristics.
METHODS: The electrophysiological data from 13 patients with anti-Nfasc155 IgG4
antibodies, 9 with anti-CNTN1 IgG4 antibodies were compared with those of 40
consecutive CIDP patients without antibodies.
RESULTS: All the patients with antibodies against Nfasc155 or CNTN1 fulfilled the
EFNS/PNS electrodiagnostic criteria for definite CIDP. There was no
electrophysiological difference between patients with anti-CNTN1 and
anti-Nfasc155 antibodies. Nerve conduction abnormalities were heterogeneously
distributed along nerves trunks and roots. They were more pronounced than in CIDP
without antibodies. Motor conduction velocity on median nerve <24 m/s or motor
velocity on ulnar nerve <26 m/s or motor distal latency on ulnar nerve >7.4 ms
were predictive of positive antibodies against the node of Ranvier with a
sensitivity of 59% and a specificity of 93%.
CONCLUSIONS: Marked conduction abnormalities may suggest the presence of positive
antibodies against the node of Ranvier.
SIGNIFICANCE: Anti-Nfasc155 and anti-CNTN1 antibodies target the the paranodal
axo-glial domain but are associated with nerve conduction abnormalities mimicking
a "demyelinating" neuropathy.
Mots-clé
Physiology (medical), Sensory Systems, Neurology, Clinical Neurology
Pubmed
Web of science
Création de la notice
15/05/2020 15:49
Dernière modification de la notice
16/05/2020 6:26
Données d'usage